Terapias Avanzadas para Tumores Sólidos Pediátricos
Institut Pasteur
París, FranciaPublicaciones en colaboración con investigadores/as de Institut Pasteur (6)
2012
-
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
Vaccine, Vol. 30, Núm. 18, pp. 2848-2858
-
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
International Journal of Cancer, Vol. 131, Núm. 3, pp. 641-651
2010
-
Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis
Vaccine, Vol. 28, Núm. 44, pp. 7146-7154
2007
-
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo
Journal of Immunology, Vol. 178, Núm. 2, pp. 748-756
2005
-
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Journal of Experimental Medicine, Vol. 202, Núm. 12, pp. 1691-1701
2004
-
Immune response against dying tumor cells
Advances in Immunology, Vol. 84, pp. 131-179